Your browser doesn't support javascript.
loading
The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients.
Atzeni, Fabiola; Alciati, Alessandra; Salaffi, Fausto; Di Carlo, Marco; Bazzichi, Laura; Govoni, Marcello; Biasi, Giovanni; Di Franco, Manuela; Mozzani, Flavio; Gremese, Elisa; Dagna, Lorenzo; Batticciotto, Alberto; Fischetti, Fabio; Giacomelli, Roberto; Guiducci, Serena; Guggino, Giuliana; Bentivegna, Mario; Gerli, Roberto; Salvarani, Carlo; Bajocchi, Gianluigi; Ghini, Marco; Iannone, Florenzo; Giorgi, Valeria; Farah, Sonia; Bonazza, Sara; Barbagli, Stefano; Gioia, Chiara; Marino, Noemi Giuliana; Capacci, Annunziata; Cavalli, Giulio; Cappelli, Antonella; Carubbi, Francesco; Nacci, Francesca; Riccucci, Ilenia; Cutolo, Maurizio; Sinigaglia, Luigi; Sarzi-Puttini, Piercarlo.
Afiliação
  • Atzeni F; Rheumatology Unit, Department of Internal Medicine, University of Messina, Messina.
  • Alciati A; Department of Clinical Neurosciences, Hermanas Hospitalarias, Villa San Benedetto Menni Hospital, Albese con Cassano, Humanitas Clinical and Research Center, Como, Milan, Rozzano.
  • Salaffi F; Rheumatology Clinic, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Ancona.
  • Di Carlo M; Rheumatology Clinic, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Ancona.
  • Bazzichi L; Rheumatology Unit, AOU Pisana, Pisa.
  • Govoni M; Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria S. Anna di Ferrara.
  • Biasi G; Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena.
  • Di Franco M; Rheumatology Unit, Department of Internal Medicine, Anesthesiological and Cardiovascular Sciences, Policlinico Umberto I, Sapienza University of Rome.
  • Mozzani F; Internal Medicine and Rheumatology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma.
  • Gremese E; Rheumatology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome.
  • Dagna L; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan.
  • Batticciotto A; Rheumatology Unit, Internal Medicine Department, ASST Settelaghi, Varese.
  • Fischetti F; Unit of Rheumatology, Department of Medical, Surgery and Health Sciences, ASUGI and Clinical University, University of Trieste.
  • Giacomelli R; Clinical Unit of Rheumatology, School of Medicine, University of L'Aquila.
  • Guiducci S; Division of Rheumatology AOUC, Department of Experimental and Clinical Medicine, University of Florence, Florence.
  • Guggino G; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo.
  • Bentivegna M; Integrated Reference Center of Rheumatology, Scicli Hospital, Ragusa.
  • Gerli R; Rheumatology Unit, Department of Medicine, University of Perugia, Perugia.
  • Salvarani C; University of Modena and Reggio Emilia, Azienda USL-IRCCS di Reggio Emilia.
  • Bajocchi G; Rheumatology Unit, S. Maria Hospital-USL, IRCCS Institute, Reggio Emilia.
  • Ghini M; Rheumatology Unit, Azienda USL di Modena.
  • Iannone F; Rheumatology Unit, Department of Emergency Surgery and Organ Transplantations, University of Bari, Bari.
  • Giorgi V; Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan University School of Medicine, Milan.
  • Farah S; Rheumatology Clinic, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Ancona.
  • Bonazza S; Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria S. Anna di Ferrara.
  • Barbagli S; Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena.
  • Gioia C; Rheumatology Unit, Department of Internal Medicine, Anesthesiological and Cardiovascular Sciences, Policlinico Umberto I, Sapienza University of Rome.
  • Marino NG; Internal Medicine and Rheumatology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma.
  • Capacci A; Rheumatology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome.
  • Cavalli G; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan.
  • Cappelli A; Rheumatology Unit, Internal Medicine Department, ASST Settelaghi, Varese.
  • Carubbi F; Clinical Unit of Rheumatology, School of Medicine, University of L'Aquila.
  • Nacci F; Division of Rheumatology AOUC, Department of Experimental and Clinical Medicine, University of Florence, Florence.
  • Riccucci I; Rheumatology Unit, Department of Medicine, University of Perugia, Perugia.
  • Cutolo M; Research Laboratory and Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCCS San Martino, Genova.
  • Sinigaglia L; Division of Rheumatology, ASST Gaetano Pini-CTO, Milano, Italy.
  • Sarzi-Puttini P; Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan University School of Medicine, Milan.
Rheumatol Adv Pract ; 5(1): rkab015, 2021.
Article em En | MEDLINE | ID: mdl-34345760
OBJECTIVE: Various studies have shown that overweight and obesity are central features of FM, but the real impact of a high BMI on clinical severity in patients with FM is still controversial. The aim of this study was to analyse the relationships between BMI categories and measures of symptom severity and functional impairment using data from a Web-based registry of patients with FM. METHODS: Adult patients with an ACR 2010/2011 diagnosis of FM underwent a complete physical examination and laboratory tests and were asked to complete a package of questionnaires covering their sociodemographic and treatment details, in addition to the following disease-specific questionnaires: the revised Fibromyalgia Impact Questionnaire (FIQR), the modified Fibromyalgia Assessment Status questionnaire (ModFAS) and the Polysymptomatic Distress Scale (PDS). RESULTS: A total of 2339 patients were recruited and divided into two weight categories, underweight/normal (U/N, n = 1127, 48.2%) and overweight/obese (O/O, n = 1212, 51.8%). The total and subscales of FIQR, ModFAS and PSD scores were significantly higher in the O/O patients, as were all the mean scores of the individual FIQR items (P < 0.001 for all). CONCLUSION: Our findings demonstrate that O/O patients with FM are significantly more impaired than U/N patients in all the symptomatological and functional domains as measured using the FIQR, ModFAS and PDS, thus suggesting that being O/O has an additional effect on symptoms and function.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article